dedifferentiated chondrosarcoma (Cancer)
Information
- Disease name
- dedifferentiated chondrosarcoma
- Disease ID
- DOID:0081247
- Description
- "A chondrosarcoma that is an aggressive morphologic variant of chondrosarcoma. It is composed of a low grade chondrosarcoma and a high grade non-cartilagenous sarcomatous component." [url:https\://pubmed.ncbi.nlm.nih.gov/34734747/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01267955 | Active, not recruiting | Phase 2 | Vismodegib in Treating Patients With Advanced Chondrosarcomas | December 21, 2010 | July 25, 2024 |
| NCT03449108 | Active, not recruiting | Phase 2 | LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas | April 27, 2018 | June 30, 2025 |
| NCT04458922 | Active, not recruiting | Phase 2 | Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma | October 5, 2020 | December 13, 2024 |
| NCT02821507 | Completed | Phase 2 | Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma | June 2014 | December 2021 |
- Disase is a (Disease Ontology)
- DOID:3371
- Cross Reference ID (Disease Ontology)
- ICDO:9243/3
- Cross Reference ID (Disease Ontology)
- NCI:C6476